189 related articles for article (PubMed ID: 26333044)
1. Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial.
Raghavan S; Geller S; Miller S; Goudar SS; Anger H; Yadavannavar MC; Dabash R; Bidri SR; Gudadinni MR; Udgiri R; Koch AR; Bellad MB; Winikoff B
BJOG; 2016 Jan; 123(1):120-7. PubMed ID: 26333044
[TBL] [Abstract][Full Text] [Related]
2. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial.
Diop A; Daff B; Sow M; Blum J; Diagne M; Sloan NL; Winikoff B
Lancet Glob Health; 2016 Jan; 4(1):e37-44. PubMed ID: 26718808
[TBL] [Abstract][Full Text] [Related]
3. A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt.
Anger HA; Dabash R; Hassanein N; Darwish E; Ramadan MC; Nawar M; Charles D; Breebaart M; Winikoff B
BMC Pregnancy Childbirth; 2020 May; 20(1):317. PubMed ID: 32448257
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of misoprostol distributed to antenatal women to prevent postpartum haemorrhage after child-births: a stepped-wedge cluster-randomized trial.
Ononge S; Campbell OM; Kaharuza F; Lewis JJ; Fielding K; Mirembe F
BMC Pregnancy Childbirth; 2015 Nov; 15():315. PubMed ID: 26610333
[TBL] [Abstract][Full Text] [Related]
5. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.
Derman RJ; Kodkany BS; Goudar SS; Geller SE; Naik VA; Bellad MB; Patted SS; Patel A; Edlavitch SA; Hartwell T; Chakraborty H; Moss N
Lancet; 2006 Oct; 368(9543):1248-53. PubMed ID: 17027730
[TBL] [Abstract][Full Text] [Related]
6. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial.
Mobeen N; Durocher J; Zuberi N; Jahan N; Blum J; Wasim S; Walraven G; Hatcher J
BJOG; 2011 Feb; 118(3):353-61. PubMed ID: 21176086
[TBL] [Abstract][Full Text] [Related]
7. Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage - Do Costs Matter?
Chatterjee S; Sarkar A; Rao KD
PLoS One; 2016; 11(10):e0164718. PubMed ID: 27755601
[TBL] [Abstract][Full Text] [Related]
8. A randomised placebo controlled trial of oral misoprostol in the third stage of labour.
Hofmeyr GJ; Nikodem VC; de Jager M; Gelbart BR
Br J Obstet Gynaecol; 1998 Sep; 105(9):971-5. PubMed ID: 9763047
[TBL] [Abstract][Full Text] [Related]
9. Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?
Hashima-E-Nasreen ; Nahar S; Al Mamun M; Afsana K; Byass P
Glob Health Action; 2011; 4():. PubMed ID: 21845143
[TBL] [Abstract][Full Text] [Related]
10. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.
Blum J; Winikoff B; Raghavan S; Dabash R; Ramadan MC; Dilbaz B; Dao B; Durocher J; Yalvac S; Diop A; Dzuba IG; Ngoc NT
Lancet; 2010 Jan; 375(9710):217-23. PubMed ID: 20060162
[TBL] [Abstract][Full Text] [Related]
11. The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in rural Uganda: a community-based, placebo-controlled randomised trial.
Weeks AD; Ditai J; Ononge S; Faragher B; Frye LJ; Durocher J; Mirembe FM; Byamugisha J; Winikoff B; Alfirevic Z
BMC Pregnancy Childbirth; 2015 Sep; 15():219. PubMed ID: 26370443
[TBL] [Abstract][Full Text] [Related]
12. Use of oral misoprostol in the prevention of postpartum haemorrhage.
el-Refaey H; O'Brien P; Morafa W; Walder J; Rodeck C
Br J Obstet Gynaecol; 1997 Mar; 104(3):336-9. PubMed ID: 9091012
[TBL] [Abstract][Full Text] [Related]
13. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial.
Høj L; Cardoso P; Nielsen BB; Hvidman L; Nielsen J; Aaby P
BMJ; 2005 Oct; 331(7519):723. PubMed ID: 16195287
[TBL] [Abstract][Full Text] [Related]
14. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
Winikoff B; Dabash R; Durocher J; Darwish E; Nguyen TN; León W; Raghavan S; Medhat I; Huynh TK; Barrera G; Blum J
Lancet; 2010 Jan; 375(9710):210-6. PubMed ID: 20060161
[TBL] [Abstract][Full Text] [Related]
15. Side-effects of oral misoprostol in the third stage of labour--a randomised placebo-controlled trial.
Hofmeyr GJ; Nikodem VC; de Jager M; Drakely A
S Afr Med J; 2001 May; 91(5):432-5. PubMed ID: 11455810
[TBL] [Abstract][Full Text] [Related]
16. The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management.
El-Refaey H; Nooh R; O'Brien P; Abdalla M; Geary M; Walder J; Rodeck C
BJOG; 2000 Sep; 107(9):1104-10. PubMed ID: 11002953
[TBL] [Abstract][Full Text] [Related]
17. Secondary prevention: a new era for postpartum haemorrhage?
Weeks AD
BJOG; 2016 Jan; 123(1):128. PubMed ID: 26412462
[No Abstract] [Full Text] [Related]
18. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour.
Walley RL; Wilson JB; Crane JM; Matthews K; Sawyer E; Hutchens D
BJOG; 2000 Sep; 107(9):1111-5. PubMed ID: 11002954
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour.
Oboro VO; Tabowei TO
J Obstet Gynaecol; 2003 Jan; 23(1):13-6. PubMed ID: 12623474
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandins for prevention of postpartum haemorrhage.
Gülmezoglu AM; Forna F; Villar J; Hofmeyr GJ
Cochrane Database Syst Rev; 2004; (1):CD000494. PubMed ID: 14973959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
